Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling

Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease

(2011) Satoshi Kurisu et al.   HEART AND VESSELS

C-Reactive Protein Overexpression Exacerbates Pressure Overload–Induced Cardiac Remodeling Through Enhanced Inflammatory Response

(2011) Toshiyuki Nagai et al.   HYPERTENSION

Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction

(2010) Masayuki Ueeda et al.   HEART AND VESSELS

C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II–Induced Hypertensive Cardiac Disease

(2010) Rongxin Zhang et al.   HYPERTENSION

Transforming growth factor (TGF)-β signaling in cardiac remodeling

(2010) Marcin Dobaczewski et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

 -3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential

(2009) M. K. Duda et al.   CARDIOVASCULAR RESEARCH

Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction

(2008) Monika K. Duda et al.   CARDIOVASCULAR RESEARCH

Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review

(2008) José Paulo Araújo et al.   JOURNAL OF CARDIAC FAILURE

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET